14-day Premium Trial Subscription Try For FreeGet Free

Range Low Price High Price Comment
30 days $23.04 $26.53 Friday, 1st Dec 2023 INSM stock ended at $26.52. This is 6% more than the trading day before Thursday, 30th Nov 2023. During the day the stock fluctuated 8.26% from a day low at $24.51 to a day high of $26.53.
90 days $23.04 $27.59
52 weeks $16.04 $27.59

Historical Insmed prices

Date Open High Low Close Volume
2023-12-01 $24.96 $26.53 $24.51 $26.52 1 674 238
2023-11-30 $25.18 $26.23 $24.78 $25.02 1 314 002
2023-11-29 $23.92 $25.17 $23.92 $25.10 1 762 862
2023-11-28 $23.90 $24.12 $23.55 $23.80 858 232
2023-11-27 $23.84 $24.21 $23.62 $23.94 1 487 690
2023-11-24 $23.73 $24.21 $23.67 $24.03 384 686
2023-11-22 $24.70 $24.70 $23.73 $23.73 771 249
2023-11-21 $24.52 $24.89 $24.19 $24.37 721 199
2023-11-20 $25.13 $25.22 $24.49 $24.62 844 661
2023-11-17 $24.65 $25.05 $24.42 $24.82 1 580 947
2023-11-16 $24.81 $24.97 $24.28 $24.44 1 552 948
2023-11-15 $24.20 $25.21 $24.08 $24.90 1 191 685
2023-11-14 $24.55 $24.90 $24.06 $24.54 1 271 051
2023-11-13 $23.48 $23.91 $23.25 $23.90 803 537
2023-11-10 $23.43 $24.01 $23.21 $23.75 747 169
2023-11-09 $23.79 $23.79 $23.04 $23.42 962 235
2023-11-08 $24.44 $24.44 $23.66 $23.75 971 005
2023-11-07 $24.03 $24.63 $23.94 $24.40 1 217 818
2023-11-06 $24.90 $25.09 $23.83 $23.84 910 174
2023-11-03 $25.35 $25.60 $24.83 $24.85 1 431 718
2023-11-02 $24.95 $25.19 $24.34 $25.01 1 099 263
2023-11-01 $25.20 $25.59 $24.88 $24.99 949 170
2023-10-31 $23.72 $25.10 $23.65 $25.06 1 041 456
2023-10-30 $24.04 $24.67 $23.75 $23.80 1 032 873
2023-10-27 $26.00 $26.00 $23.62 $23.88 1 986 013
Click to get the best stock tips daily for free!

About Insmed

Insmed Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversible inhibitor of dipeptidyl peptidase 1 for the treatment of patients with bronchiectasis and other neutr... INSM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT